Online now!

Sharon Cantor and team report that increased DNA end resection in BRCA-deficient, PARP inhibitor-resistant cancers leads to increased sensitivity to DNA nicks, limiting tumor formation in mice, and propose the therapeutic exploration of nickases

👇
https://www.nature.com/articles/s43018-024-00902-1?utm_source=bluesky&utm_medium=social&utm_campaign=natcancer